Keep up to date with our latest partnering deals and highlights

Below is a selection of news releases describing recent deals completed by AstraZeneca and our biologics arm, MedImmune.

Friday, 22 November 2013
AstraZeneca wins two Scrip Awards Best Partnership Alliance for the fourth year in a row, and Best Licensing Deal of the Year at the 9th Annual Scrip Awards 2013
Tuesday, 15 October 2013
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology.
Friday, 11 October 2013
AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostate cancer treatment AstraZeneca today announced that it has entered into an agreement with Janssen Pharmaceuticals K. K. in Japan to co-promote abiraterone acetate, an innovative oral therapy for the treatment of patients with prostate cancer.
Download our brochure

Download your comprehensive guide to partnering with us.


Meet us at an event

Calendar iconView our full event calendar to see events we are attending.

View calendar